Rad AI Raises $60M Series C at $525M Valuation to Expand AI-Powered Radiology Solutions
Rad AI is revolutionizing radiology with cutting-edge generative AI, enabling radiologists to work more efficiently while improving patient care.
Company Name: Rad AI
Location: San Francisco, CA
Industry: Health Tech
Funding Details
- Amount: $60M (Series C)
- Valuation: $525M
- Investors:
- Lead: Transformation Capital
- Participants: Khosla Ventures, World Innovation Lab, UP2398, Kickstart Fund, OCV Partners, Cone Health, and others.
- Previous Round: $50M Series B
Purpose of Investment
- Expand operations to support growing demand.
- Advance R&D efforts to enhance AI-driven radiology solutions.
Leadership
- CEO: Doktor Gurson
Product
Rad AI develops generative AI solutions for radiology, helping radiologists improve efficiency, accuracy, and patient outcomes.
Key Features
- Rad AI Reporting: AI-driven automation for radiology report generation, reducing workload and improving consistency.
- Rad AI Impressions: Generative AI-powered assistance for radiologists, already used by thousands of U.S. radiologists.
- Rad AI Continuity: AI-driven follow-up system to help ensure early detection of potential new cancers.
About the Company
Rad AI is revolutionizing radiology with cutting-edge generative AI, enabling radiologists to work more efficiently while improving patient care. The company’s AI-driven solutions optimize workflow, enhance reporting accuracy, and facilitate early cancer detection, making it a key player in AI-powered healthcare innovation.
Future Plans
With this funding, Rad AI will scale its operations, accelerate product development, and further integrate AI-driven solutions into radiology workflows to support radiologists and improve patient outcomes.
